Portal de Periódicos da CAPES

Endothelial Activation by Cytokines a

1997; Wiley; Volume: 832; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1997.tb46240.x

1749-6632

Alberto Mantovani, Silvano Sozzani, Martino Introna,

Plant-based Medicinal Research

Annals of the New York Academy of SciencesVolume 832, Issue 1 p. 93-116 Endothelial Activation by Cytokinesa ALBERTO MANTOVANI, Corresponding Author ALBERTO MANTOVANI Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, Italy Section of General Pathology Department of Biotechnology Università di Brescia Address correspondence to: Prof. Alberto Mantovani, Istituto di Ricerche Farmacologiche "Mario Negri," via Eritrea 62, 20157 Milano, Italy. Phone, (02)39014.1; Fax, (02)3546277; E-mail, [email protected].Search for more papers by this authorSILVANO SOZZANI, SILVANO SOZZANI Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, ItalySearch for more papers by this authorMARTINO INTRONA, MARTINO INTRONA Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, ItalySearch for more papers by this author ALBERTO MANTOVANI, Corresponding Author ALBERTO MANTOVANI Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, Italy Section of General Pathology Department of Biotechnology Università di Brescia Address correspondence to: Prof. Alberto Mantovani, Istituto di Ricerche Farmacologiche "Mario Negri," via Eritrea 62, 20157 Milano, Italy. Phone, (02)39014.1; Fax, (02)3546277; E-mail, [email protected].Search for more papers by this authorSILVANO SOZZANI, SILVANO SOZZANI Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, ItalySearch for more papers by this authorMARTINO INTRONA, MARTINO INTRONA Istituto di Ricerche Farmacologiche "Mario Negri" via Eritrea 62 20157 Milan, ItalySearch for more papers by this author First published: 17 December 2006 https://doi.org/10.1111/j.1749-6632.1997.tb46240.xCitations: 41 a This work supported by special project AIDS from Istituto Superiore della Sanità and by the Italian Association for Cancer Research Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Mantovani, A. & E. Dejana. 1989. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today. 10: 370–375. 2 Pober, J. & R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70: 427–451. 3 Libby, P. & G. K. Hansson. 1991. Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64: 5–15. 4 Mantovani, A., F. Bussolino & E. Dejana. 1992. Cytokine regulation of endothelial cell function. FASEB. J. 6: 2591–2599. 5 Bussolino, F., M. Arese, L. Silvestro et al 1994. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha. Eur. J. Immunol. 24: 3131–3139. 6 Bussolino, F. & G. Camussi. 1995. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem. 229: 327–337. 7 Montrucchio, G., E. Lupia, E. Battaglia et al 1994. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180: 377–382. 8 Jackson, B. A., R. H. Goldstein, R. Roy, M. Cozzani, L. Taylor & P. Polgar. 1993. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. 197: 1465–1474. 9 Camacho, M., N. Godessart, R. Anton, M. Garcia & L. Vila. 1995. Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270: 17279–17286. 10 Claria, J. & C. N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92: 9475–9479. 11 Nathan, C. & Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915–918. 12 Rosenkranz Weiss, P., W. C. Sessa, S. Milstien, S. Kaufman, C. A. Watson & J. S. Pober. 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93: 2236–2243. 13 Werner Felmayer, G., E. R. Werner, D. Fuchs et al. 1993. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol. Chem. 268: 1842–1846. 14 Yoshizumi, M., M. A. Perrella, J. C. Burnett, Jr. & M. E. Lee. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205–209. 15 Lamas, S., T. Michel, T. Collins, B. M. Brenner & P. A. Marsden. 1992. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J. Clin. Invest. 90: 879–887. 16 Radomski, M. W., R. M. Palmer & S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87: 10043–10047. 17 Suschek, C., H. Rothe, K. Fehsel, J. Enczmann & V. Kolb Bachofen. 1993. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J. Immunol. 151: 3283–3291. 18 Balligand, J. L., D. Ungureanu Longrois, W. W. Simmons et al. 1995. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am. J. Physiol. 268: H1293–H1303. 19 Martin, E., C. Nathan & Q. W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180: 977–984. 20 Kamijo, R., H. Harada, T. Matsuyama et al 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612–1615. 21 Zhang, R., W. Min & W. C. Sessa. 1995. Functional analysis of the human endothelial nitric oxide synthase promoter. Spl and GATA factors are necessary for basal transcription in endothelial cells. J. Biol. Chem. 270: 15320–15326. 22 Sakurai, H., H. Kohsaka, M. F. Liu et al. 1995. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96: 2357–2363. 23 Cobbs, C. S., J. E. Brenman, K. D. Aldape, D. S. Bredt & M. A. Israel. 1995. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55: 727–730. 24 Murata, J., S. B. Corradin, E. Felley Bosco & L. Juillerat Jeanneret. 1995. Involvement of a transforming-growth-factor-beta-like molecule in tumor-cell-derived inhibition of nitric-oxide synthesis in cerebral endothelial cells. Int. J. Cancer 62: 743–748. 25 Inoue, N., R. C. Venema, H. S. Sayegh, Y. Ohara, T. J. Murphy & D. G. Harrison. 1995. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler. Thromb. Vasc. Biol. 15: 1255–1261. 26 Niu, X. F., C. W. Smith & P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74: 1133–1140. 27 De Caterina, R., P. Libby, H. B. Peng et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96: 60–68. 28 Peng, H. B., T. B. Rajavashisth, P. Libby & J. K. Liao. 1995. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270: 17050–17055. 29 Zeiher, A. M., B. Fisslthaler, B. Schray Utz & R. Busse. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76: 980–986. 30 Peng, H. B., P. Libby & J. K. Liao. 1995. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270: 14214–14219. 31 Oswald, I. P., I. Eltoum, T. A. Wynn et al. 1994. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc. Natl. Acad. Sci. USA 91: 999–1003. 32 Ziche, M., L. Morbidelli, E. Masini et al 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94: 2036–2044. 33 Fukuo, K., T. Inoue, S. Morimoto et al 1995. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J. Clin. Invest. 95: 669–676. 34 Von Der Leyen, H. E., G. H. Gibbons, R. Morishita et al. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92: 1137–1141. 35 Schulz, R., D. L. Panas, R. Catena, S. Moncada, P. M. Olley & G. D. Lopaschuk. 1995. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br. J. Pharmacol. 114: 27–34. 36 Sato, K., K. Miyakawa, M. Takeya et al. 1995. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J. Leukoc. Biol. 57: 36–44. 37 Romer, L. H., N. V. Mclean, H. C. Yan, M. Daise, J. Sun & H. M. Delisser. 1995. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol. 154: 6582–6592. 38 Heller, R., F. Bussolino, D. Ghigo et al 1992. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J. Immunol. 149: 3682–3688. 39 Bussolino, F., F. Silvagno, G. Garbarino et al 1994. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. J. Biol. Chem. 269: 2877–2886. 40 Hill, M. E., I. N. Bird, R. H. Daniels, M. A. Elmore & M. J. Finnen. 1994. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. J. Immunol. 153: 3673–3683. 41 Kilgore, K. S., J. P. Shen, B. F. Miller, P. A. Ward & J. S. Warren. 1995. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155: 1434–1441. 42 Saadi, S., R. A. Holzknecht, C. Patte, D. M. Stern & J. L. Platt. 1995. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182: 1807–1814. 43 Coulpier, M., S. Andreev, C. Lemercier et al 1995. Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin. Exp. Immunol. 101: 142–149. 44 Opipari, A. W. J., H. M. Hu, R. Yabkowitz & V. M. Dixit. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267: 12424–12427. 45 Wolf, F. W., R. M. Marks, V. Sarma et al 1992. Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. J. Biol. Chem. 267: 1317–1326. 46 Wolf, F. W., V. Sarma, M. Seldin et al 1994. B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J. Biol. Chem. 269: 3633–3640. 47 Holzman, L. B., R. M. Marks & V. M. Dixit. 1990. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol. Cell Biol. 10: 5830–5838. 48 Pandey, A., H. Shao, R. M. Marks, P. J. Polverini & V. M. Dixit. 1995. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268: 567–569. 49 Lee, T. H., G. W. Lee, E. B. Ziff & J. Vilcek. 1990. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell Biol. 10: 1982–1988. 50 Breviario, F., E. M. D'aniello, J. Golay et al 1992. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J. Biol. Chem. 267: 22190–22197. 51 Introna, M., V. Vidal Alles, M. Castellano et al. 1996. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 87: 1862–1872. 52 Maier, J. A., P. Voulalas, D. Roeder & T. Maciag. 1990. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 249: 1570–1574. 53 Maier, J. A., M. Statuto & G. Ragnotti. 1994. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell Biol. 14: 1845–1851. 54 Bertini, R., M. Sironi, I. Martin Padura et al. 1992. Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation. Cytokine 4: 44–47. 55 Bradley, J. R., S. Thiru & J. S. Pober. 1995. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am. J. Pathol. 146: 27–32. 56 Mackay, F., H. Loetscher, D. Stueber, G. Gehr & W. Lesslauer. 1993. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177: 1277–1286. 57 Paleolog, E. M., S. A. Delasalle, W. A. Buurman & M. Feldmann. 1994. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 84: 2578–2590. 58 Slowik, M. R., L. G. De Luca, W. Fiers & J. S. Pober. 1993. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am. J. Pathol. 143: 1724–1730. 59 Tartaglia, L. A., D. Pennica & D. V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268: 18542–18548. 60 Grell, M., E. Douni, H. Wajant et al 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793–802. 61 Schmid, E. F., K. Binder, M. Grell, P. Scheurich & K. Pfizenmaier. 1995. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood 86: 1836–1841. 62 Lukacs, N. W., R. M. Strieter, V. Elner, H. L. Evanoff, M. D. Burdick & S. L. Kunkel. 1995. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood 86: 2767–2773. 63 Colotta, F., M. Sironi, A. Borre et al 1993. Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. Blood 81: 1347–1351. 64 Colotta, F., F. Re, M. Muzio et al 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472–475. 65 Van De Kar, N. C., T. Kooistra, M. Vermeer, W. Lesslauer, L. A. Monnens & V. W. Van Hinsbergh. 1995. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood 85: 734–743. 66 Yan, S. F., I. Tritto, D. Pinsky et al 1995. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J. Biol. Chem. 270: 11463–11471. 67 Grosset, C., B. Jazwiec, J. L. Taupin et al. 1995. In vitro biosynthesis of leukemia inhibitory facto r/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 86: 3763–3770. 68 Suen, Y., M. Chang, S. M. Lee, J. S. Buzby & M. S. Cairo. 1994. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84: 4125–4134. 69 Sironi, M., F. Breviario, P. Proserpio et al 1989. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142: 549–553. 70 Meininger, C. J., S. E. Brightman, K. A. Kelly & B. R. Zetter. 1995. Increased stem cell factor release by hemangioma-derived endothelial cells. Lab. Invest. 72: 166–173. 71 Rajavashisth, T. B., A. Andalibi, M. C. Territo et al. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254–257. 72 Bussolino, F., E. Bocchietto, F. Silvagno, R. Soldi, M. Arese & A. Mantovani. 1994. Actions of molecules which regulate hemopoiesis on endothelial cells: memoirs of common ancestors Path. Res. Pract. 190: 834–839. 73 Shyy, Y. J., L. L. Wickham, J. P. Hagan et al. 1993. Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers. J. Clin. Invest. 92: 1745–1751. 74 Korpelainen, E. I., J. R. Gamble, W. B. Smith, M. Bottore, M. A. Vadas & A. F. Lopez. 1995. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 86: 176–182. 75 Sironi, M., C. Munoz, T. Pollicino et al 1993. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur. J. Immunol. 23: 2692–2695. 76 Chen, C. C. & A. M. Manning. 1996. TGF-betal, IL-10 and IL-4 differentially modulate the cytokine-induced expression of the IL-6 and IL-8 in human endothelial cells. Cytokine 8: 58–65. 77 Debeaux, A. C., J. P. Maingay, J. A. Ross, K. C. H. Fearon & D. C. Carter. 1995. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J. Interferon Cytokine Res. 15: 441–445. 78 Vora, M., H. Yssel, J. E. De Vries & M. A. Karasek. 1994. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J. Immunol. 152: 5734–5741. 79 Schoedon, G., M. Schneemann, N. Blau, C. J. Edgell & A. Schaffner. 1993. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun. 196: 1343–1348. 80 Eissner, G., F. Kohlhuber, M. Grell et al 1995. Critical involvement of transmem-brane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86: 4184–4193. 81 Krakauer, T. 1995. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol. Lett. 45: 61–65. 82 Wojta, J., M. Gallicchio, H. Zoellner, E. L. Filonzi, J. A. Hamilton & K. Mcgrath. 1993. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 81: 3285–3292. 83 Marfaingkoka, A., O. Devergne, G. Gorgone et al 1995. Regulation of the production of the RANTES chemokine by endothelial cells—Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 154: 1870–1878. 84 Sironi, M., F. L. Sciacca, C. Matteucci et al 1994. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84: 1913–1921. 85 Garcia De Frutos, P., Y. Hardig & B. Dahlback. 1995. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270: 26950–26955. 86 Hollenbaugh, D., N. Mischel Petty, C. P. Edwards et al. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182: 33–40. 87 Yellin, M. J., J. Brett, D. Baum et al 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182: 1857–1864. 88 Karmann, K., C. C. Hughes, J. Schechner, W. C. Fanslow & J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92: 4342–4346. 89 Voest, E. E., B. M. Kenyon, M. S. O'reilly, G. Truitt, R. J. D'amato & J. Folkman. 1995. Inhibition of angiogenesis in vivo by interleukin-12. J. Natl. Cancer Inst. 87: 581–586. 90 Ezekowitz, R. A., J. B. Mulliken & J. Golkman. 1992. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy [see comments] [published errata appear in N Engl J Med 1994 Jan 27;330(4):300 and 1995 Aug 31;333(9):595-6]. N. Engl. J. Med. 326: 1456–1463. 91 Gyetko, M. R., S. B. Shollenberger & R. G. Sitrin. 1992. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha. J. Leukoc. Biol. 51: 256–263. 92 Galea, P., G. Thibault, M. Lacord, P. Bardos & Y. Lebranchu. 1993. IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J. Immunol. 151: 588–596. 93 Cushing, S. D., J. A. Berlines, A. J. Valente et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87: 5134–5138. 94 Colotta, F., F. L. Sciacca, M. Sironi, W. Luini, M. J. Rabiet & A. Mantovani. 1994. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am. J. Pathol. 144: 975–985. 95 Qi, J. F. & D. L. Kreutzer. 1995. Fibrin activation of vascular endothelial cells—Induction of IL-8 expression. J. Immunol. 155: 867–876. 96 Korpelainen, E. I., J. R. Gamble, W. B. Smith et al. 1993. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration. Proc. Natl. Acad. Sci. USA 90: 11137–11141. 97 Jeannin, P., Y. Delneste, P. Gosset et al 1994. Histamine induces interleukin-8 secretion by endothelial cells. Blood 84: 2229–2233. 98 Kaplanski, G., R. Porat, K. Aiura, J. K. Erban, J. A. Gelfand & C. A. Dinarello. 1993. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an inter-leukin-1 mediated event. Blood 81: 2492–2495. 99 Karakurum, M., R. Shreeniwas, J. Chen et al. 1994. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93: 1564–1570. 100 Kaplanski, G., R. Porat, K. Aiura, J. K. Erban, J. A. Gelfand & C. A. Dinarello. 1993. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81: 2492–2495. 101 Kaplanski, G., C. Farnarier, S. Kaplanski et al 1994. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 4242–4248. 102 Narumi, S., L. M. Wyner, M. H. Stoler, C. S. Tannenbaum & T. A. Hamilton. 1992. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon-gamma. J. Leukoc. Biol. 52: 27–33. 103 Gómez-chiarri, M., T. A. Hamilton, J. Egido & S. N. Emancipator. 1993. Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am. J. Pathol. 142: 433–439. 104 Devergne, O., A. Marfaing-koka, T. J. Schall et al. 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells. J. Exp. Med. 179: 1689–1694. 105 Pattison, J., P. J. Nelson, P. Huie et al 1994. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 343: 209–211. 106 Brown, Z., M. E. Gerritsen, W. W. Carley, R. M. Strieter, S. L. Kunkel & J. Westwick. 1994. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells—Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am. J. Pathol. 145: 913–921. 107 Koch, A. E., P. J. Polverini, S. L. Kunkel et al. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798–1801. 108 Strieter, R. M., S. L. Kunkel, V. M. Elner et al. 1992. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141: 1279–1284. 109 Wen, D., A. Rowland & R. Derynck. 1989. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J. 8: 1761–1766. 110 Schonbeck, U, E. Brandt, F. Petersen, H. D. Flad & H. Loppnow. 1995. IL-8 specifically binds to endothelial but not to smooth muscle cells. J. Immunol. 154: 2375–2383. 111 Petzelbauer, P., C. A. Watson, S. E. Pfau & J. S. Pober. 1995. IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 7: 267–272. 112 Maione, T. E., G. S. Gray, J. Petro et al 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77–79. 113 Luster, A. D., S. M. Greenberg & P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182: 219–231. 114 Angiolillo, A. L., C. Sgadari, D. D. Taub et al. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182: 155–162. 115 Strieter, R. M., P. J. Polverini, S. L. Kunkel et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270: 27348–27357. 116 Cao, Y. H., C. Chen, J. A. Weatherbee, M. Tsang & J. Folkman. 1995. Gro-beta, a-C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182: 2069–2077.